We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
Cap. Flow
-$37.3M
Cap. Flow %
-11.13%
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134

Top Buys

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$16M
2
STM icon
STMicroelectronics
STM
+$13.6M
3
APH icon
Amphenol
APH
+$10.9M
4
STX icon
Seagate
STX
+$7.07M
5
F icon
Ford
F
+$6.02M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$18.4M
2
LITE icon
Lumentum
LITE
+$14.5M
3
AXTI icon
AXT Inc
AXTI
+$13.3M
4
TSEM icon
Tower Semiconductor
TSEM
+$11.9M
5
MU icon
Micron Technology
MU
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 38.35%
2 Healthcare 29.66%
3 Financials 6.33%
4 Miscellaneous 6.14%
5 Consumer Discretionary 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRH icon
76
CRH
CRH
$61.2B
$822K 0.25%
7,678
-3,565
-32% -$392K
Q
77
Qnity Electronics Inc
Q
$24.8B
$791K 0.24%
4,844
-270
-5% -$39.8K
IVA
78
Inventiva
IVA
$1.14B
$791K 0.24%
209,182
+81,083
+63% +$390K
BTG icon
79
B2Gold
BTG
$7.52B
$781K 0.23%
+208,812
New +$958K
SYRE icon
80
Spyre Therapeutics
SYRE
$7.69B
$778K 0.23%
8,760
+3,957
+82% +$289K
LPG icon
81
Dorian LPG
LPG
$2.29B
$774K 0.23%
+21,951
New +$864K
AZN icon
82
AstraZeneca
AZN
$256B
$769K 0.23%
4,058
+2,822
+228% +$531K
NRIX icon
83
Nurix Therapeutics
NRIX
$2.63B
$751K 0.22%
+30,973
New +$528K
CRBP icon
84
Corbus Pharmaceuticals
CRBP
$222M
$722K 0.22%
76,919
-34,307
-31% -$325K
MRVL icon
85
Marvell Technology
MRVL
$188B
$721K 0.22%
2,421
-12,261
-84% -$2.46M
VERA icon
86
Vera Therapeutics
VERA
$2.52B
$707K 0.21%
+16,485
New +$614K
FSLR icon
87
First Solar
FSLR
$22.3B
$702K 0.21%
3,013
-163
-5% -$38.2K
CAPR icon
88
CALL
Capricor Therapeutics
CAPR
$540M
$697K 0.21%
831
– –
ORKA
89
Oruka Therapeutics
ORKA
$6.02B
$674K 0.2%
+7,085
New +$472K
DFTX
90
Definium Therapeutics
DFTX
$5.11B
$648K 0.19%
13,778
-2,083
-13% -$51.5K
GH icon
91
Guardant Health
GH
$21.6B
$641K 0.19%
4,275
+189
+5% +$20.6K
DAR icon
92
Darling Ingredients
DAR
$10.4B
$633K 0.19%
11,901
+2,243
+23% +$134K
PBF icon
93
PBF Energy
PBF
$8.93B
$632K 0.19%
13,606
+7,188
+112% +$299K
SNY icon
94
Sanofi
SNY
$106B
$629K 0.19%
14,750
+4,804
+48% +$215K
BE icon
95
Bloom Energy
BE
$69.4B
$622K 0.19%
2,054
+1,809
+738% +$463K
TMO icon
96
Thermo Fisher Scientific
TMO
$229B
$619K 0.18%
1,235
+732
+146% +$351K
SYK icon
97
Stryker
SYK
$118B
$604K 0.18%
1,918
+808
+73% +$255K
RLMD icon
98
Relmada Therapeutics
RLMD
$466M
$598K 0.18%
86,443
+35,670
+70% +$249K
UNH icon
99
UnitedHealth
UNH
$360B
$593K 0.18%
+1,427
New +$529K
WGS icon
100
GeneDx Holdings
WGS
$2.61B
$587K 0.18%
+8,555
New +$486K
2 3
4
5 6

Similar funds

JWM
Jessup Wealth Management Dayton, Ohio $335M AUM 56.2% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $335M AUM 97.32% 1-Year Est. Return
TFA
TPG Financial Advisors Portland, Oregon $335M AUM 14.14% 1-Year Est. Return
SIM
Seaview Investment Managers Miami, Florida $335M AUM 47.2% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $336M AUM 20.38% 1-Year Est. Return
SS
Spinecap SAS Paris, France $335M AUM 16.94% 1-Year Est. Return
BIA
BHK Investment Advisors Birmingham, Alabama $335M AUM 20.89% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

Persistent Asset Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.

  • Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
  • Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
  • Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
  • Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
  • Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
  • Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
  • Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.